Botulinum as a Toxin for Treating Post-herpetic Neuralgia
Background: We aimed to study the curative effects of botulinum A toxin (BTX-A) on the treatment of post-herpetic neuralgia (PNH).
Methods: We enrolled 58 PNH patients and treated them with hypodermic injection of BTX-A in Xiangyang No.1 People’s Hospital, Hubei University of Medicine, Hubei, China. We measured and compared the Visual Analog Score (VAS), Neuropathy Pain Scale (NPS), Quality of Life Scale (SF-36) score, PNH seizure severity degree, seizure duration, frequency of attack and the use of painkillers before and after treatment. We used SPSS13 software package for statistical analysis. Values were expressed by mean± standard deviation. P<0.05 indicated a significant difference and P<0.01 indicated an obvious significant difference.
Results: Attack frequency, attack duration and attack severity were all significantly lower after treatment (P<0.01). The use of painkillers reduced after treatment (P<0.01) and we observed very few adverse reactions associated with BTX-A injection.
Conclusion: The use of BTX-A for treating post-herpetic neuralgia produced very promising results with very few adverse reactions. BTX-A can be considered as a valid approach in the treatment of PNH, especially in patients that do not respond well to painkillers.
Xiao L, Mackey S, Hui H, Xong D, Zhang Q, Zhang D (2010). Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. Pain Med, 11:1827-33.
Sotiriou E, Apalla Z, Panagiotidou D, Ioannidis D (2009). Severe post-herpetic neuralgia successfully treated with botulinum toxin A: three case reports. Acta Derm Venereol, 89:214-5.
Liu HT, Tsai SK, Kao MC, Hu JS (2006). Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia. Pain Med, 7(1):789-91.
Xiaohu S, Wen S, Jinglang Z (2008). Clinical observation of botulinum A toxin in the treatment of postherpetic neuralgia. Practical Study of Pain, 4326-30.
Haipeng L, Yanfeng S, Xiandong W (2009). Clinical study on botulinum A toxin in the treatment of post herpetic neuralgia. Shandong Medicine, 49:71-4.
Dodick DW (2003). Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside. Headache, 43: S25-33.
Jobel H (2004). Botulinum toxin in migraine prophylaxis. J Neurol, 251:18-11.
Aoki KR (2003). Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache, 43: S9-15.
Mense S (2004). Neurohiological basis for the use of botulinum toxin in pain therapy. J Neurol, 251 Suppl. 1:I1-7.
|Issue||Vol 46 No 5 (2017)|
|Postherpetic neuralgia Botulinum a toxin Treatment|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|